APA
Froissart A., Buffet M., Veyradier A., Poullin P., Provôt F., Malot S., Schwarzinger M., Galicier L., Vanhille P., Vernant J., Bordessoule D., Guidet B., Azoulay E., Mariotte E., Rondeau E., Mira J., Wynckel A., Clabault K., Choukroun G., Presne C., Pourrat J., Hamidou M. & Coppo P. (20120215). Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center. : Critical care medicine.
Chicago
Froissart Antoine, Buffet Marc, Veyradier Agnès, Poullin Pascale, Provôt François, Malot Sandrine, Schwarzinger Michael, Galicier Lionel, Vanhille Philippe, Vernant Jean-Paul, Bordessoule Dominique, Guidet Bertrand, Azoulay Elie, Mariotte Eric, Rondeau Eric, Mira Jean-Paul, Wynckel Alain, Clabault Karine, Choukroun Gabriel, Presne Claire, Pourrat Jacques, Hamidou Mohamed and Coppo Paul. 20120215. Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center. : Critical care medicine.
Harvard
Froissart A., Buffet M., Veyradier A., Poullin P., Provôt F., Malot S., Schwarzinger M., Galicier L., Vanhille P., Vernant J., Bordessoule D., Guidet B., Azoulay E., Mariotte E., Rondeau E., Mira J., Wynckel A., Clabault K., Choukroun G., Presne C., Pourrat J., Hamidou M. and Coppo P. (20120215). Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center. : Critical care medicine.
MLA
Froissart Antoine, Buffet Marc, Veyradier Agnès, Poullin Pascale, Provôt François, Malot Sandrine, Schwarzinger Michael, Galicier Lionel, Vanhille Philippe, Vernant Jean-Paul, Bordessoule Dominique, Guidet Bertrand, Azoulay Elie, Mariotte Eric, Rondeau Eric, Mira Jean-Paul, Wynckel Alain, Clabault Karine, Choukroun Gabriel, Presne Claire, Pourrat Jacques, Hamidou Mohamed and Coppo Paul. Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center. : Critical care medicine. 20120215.